Phyllantidin

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: Phyllantidin
• 英文别名: (6S)-(12ac)-10,11,12,12a-tetrahydro-6H,9H-6r,12bc-methano-furo[2,3-d]pyrido[1,2-b][1,2]oxazocin-2-one；(2α)-1(7)a-oxa-1(7)a-homo-securinan-11-one；8,15-Dioxa-7-azatetracyclo[7.6.1.01,12.02,7]hexadeca-10,12-dien-14-one
• 化学式: C₁₃H₁₅NO₃
• 分子量: 233.267
• InChiKey: CTFXYMMZXWWOFY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  17
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• [EN] SMALL MOLECULE SECURININE AND NORSECURININE ANALOGS AND THEIR USE IN INHIBITING MYELOPEROXIDASE<br/>[FR] ANALOGUES DE SÉCURININE ET DE NORSÉCURININE À PETITES MOLÉCULES ET LEUR UTILISATION POUR INHIBER LA MYÉLOPEROXYDASE
  申请人：MIRX PHARMACEUTICALS LLC

  公开号：WO2015051276A1

  公开（公告）日：2015-04-09

  The present invention relates to novel securinine and norsecurine analogs that have reduced or non-reduced gamma-delta bond. The present invention also provides for methods of using securinine analogs, comprising administering one or more of the analogs to a myeloperoxidase enzyme, such as an enzyme with or proximal to a cell. As set out herein, the securinine analogs directly bind to and inhibit myeloperoxidase (MPO) activity. Accordingly, contacting or administering the analogs to an MPO enzyme allows for inhibition of MPO activity.

  本发明涉及一种具有减少或未减少γ-δ键的新型安全琳和诺安全琳类似物。本发明还提供了使用安全琳类似物的方法，包括将一个或多个类似物给予髓过氧化物酶酶，例如与细胞接近或接近的酶。如本文所述，安全琳类似物直接结合并抑制髓过氧化物酶（MPO）活性。因此，将类似物与MPO酶接触或给予类似物可使MPO活性受到抑制。
• SMALL MOLECULE SECURININE AND NORSECURININE ANALOGS AND THEIR USE IN CANCERS, INFLAMMATORY DISEASES AND INFECTIONS
  申请人：GUNDLURU Mahesha K.

  公开号：US20160229861A1

  公开（公告）日：2016-08-11

  The present invention relates to novel securinine and norsecurine analogs and their applicapility in treating cellular proliferative disorders.
• SMALL MOLECULE SECURININE AND NORSECURININE ANALOGS AND THEIR USE IN INHIBITING MYELOPEROXIDASE
  申请人：GUNDLURU Mahesh K.

  公开号：US20160250196A1

  公开（公告）日：2016-09-01

  The present invention relates to novel securinine and norsecurine analogs that have reduced or non-reduced gamma-delta bond. The present invention also provides for methods of using securinine analogs, comprising administering one or more of the analogs to a myeloperoxidase enzyme, such as an enzyme with or proximal to a cell. As set out herein, the securinine analogs directly bind to and inhibit myeloperoxidase (MPO) activity. Accordingly, contacting or administering the analogs to an MPO enzyme allows for inhibition of MPO activity.
• US9827229B2
  申请人：——

  公开号：US9827229B2

  公开（公告）日：2017-11-28
• [EN] SMALL MOLECULE SECURININE AND NORSECURININE ANALOGS AND THEIR USE IN CANCERS INFLAMMATORY DISEASES AND INFECTIONS<br/>[FR] ANALOGUES DE SÉCURININE ET DE NORSÉCURININE À PETITES MOLÉCULES ET UTILISATION DE CES DERNIERS DANS LES CANCERS, LES MALADIES INFLAMMATOIRES ET LES INFECTIONS
  申请人：INVENIO THERAPEUTICS INC

  公开号：WO2015051284A2

  公开（公告）日：2015-04-09

  The present invention relates to novel securinine and norsecurine analogs and their applicapility in treating cellular proliferative disorders.